Who
James Woodruff Lillie
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, MapLight Therapeutics; Chief Scientific Officer, Tempest Therapeutics.
In numbers
- Trades disclosed
- 55
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $5.2M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 6 Mar 2018
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $93K11,513 at $8.08 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —7,730 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,395 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,395 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —7,730 at $0.00 | filing |
| 3 Aug 2026filed 4 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $277K22,082 at $12.54 | filing |
| 3 Aug 2026filed 4 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $277K22,082 at $12.54 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $79K2,077 at $37.90 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $79K2,077 at $37.90 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $183K5,009 at $36.45 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $131K3,526 at $37.26 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $45612 at $37.96 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $183K5,009 at $36.45 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $131K3,526 at $37.26 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $45612 at $37.96 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $81K2,238 at $36.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $199K5,393 at $36.99 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $45012 at $37.54 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $81K2,238 at $36.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $199K5,393 at $36.99 | filing |
News
No headline names them, or the companies they trade most, lately.